# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-20T10:43:33.782038
**Route:** Direct Google API + PDF
**Tokens:** 18917 in / 1856 out
**Response SHA256:** 794f920dfdf291a0

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Behavioral Health Claims by State-Month"
**Page:** 10
- **Formatting:** Clean and professional. Use of horizontal rules follows standard journal (AER/QJE) style (booktabs).
- **Clarity:** Very high. The variables are intuitive, and the scale of the data is clear.
- **Storytelling:** Essential. It establishes the scale of the T-MSIS data and the variation across states. 
- **Labeling:** Good. It explicitly defines the N, the timeframe, and the HCPCS codes in the notes.
- **Recommendation:** **KEEP AS-IS**

### Figure 1: "Cumulative Adoption of Telehealth Payment Parity Laws"
**Page:** 14
- **Formatting:** Professional "clean" look. The dashed line for the COVID PHE is a helpful reference.
- **Clarity:** Good. It clearly shows the 2021 adoption wave.
- **Storytelling:** Vital for a staggered DiD paper. It justifies the choice of the 2021 cohort as the "Main Wave" in later figures.
- **Labeling:** Clear axes and source notes. 
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Behavioral Health Provider Supply by Treatment Cohort"
**Page:** 15
- **Formatting:** Modern and clean. The color palette is distinguishable. 
- **Clarity:** The "Main Wave" label is useful. The Y-axis transformation ($ln(Providers + 1)$) is clearly labeled.
- **Storytelling:** This is the most important "raw data" figure. It visually validates the parallel trends assumption before any econometrics are applied.
- **Labeling:** Fully specified.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Effect of Telehealth Parity on Behavioral Health: TWFE"
**Page:** 16
- **Formatting:** Standard three-line table. Numbers are logically aligned.
- **Clarity:** High. Grouping the four main outcomes in one table allows for easy comparison.
- **Storytelling:** Important as a baseline, though the paper correctly notes that CS (Table 3) is the preferred estimator.
- **Labeling:** Note defines significance stars and standard error clustering.
- **Recommendation:** **KEEP AS-IS**

### Figure 3: "Event Study: Effect of Telehealth Parity on Behavioral Health Provider Supply"
**Page:** 16
- **Formatting:** Clean. The shaded 95% confidence intervals are standard.
- **Clarity:** Very high. The reference period ($t=-1$) is clearly noted.
- **Storytelling:** This is the "money shot" of the paper—the visual evidence of the null result.
- **Labeling:** Axis labels are clear.
- **Recommendation:** **REVISE**
  - **Change:** Add the "Overall ATT" point estimate and its standard error as a text annotation inside the plot area (e.g., in the top right corner) to consolidate the key takeaway.

### Table 3: "Callaway-Sant’Anna Overall ATT Estimates"
**Page:** 17
- **Formatting:** Professional.
- **Clarity:** The "Implied % Change" column is an excellent addition that makes the log coefficients interpretable for policymakers.
- **Storytelling:** This is the primary results table.
- **Labeling:** Notes are comprehensive.
- **Recommendation:** **KEEP AS-IS** (Consider merging with Table 2 if space is at a premium, but separate is fine for clarity).

### Figure 4: "Event Study: Effect of Telehealth Parity on Behavioral Health Beneficiaries"
**Page:** 18
- **Formatting:** Identical to Figure 3.
- **Clarity:** Clear.
- **Storytelling:** Shows the null holds for the intensive margin.
- **Labeling:** Correct.
- **Recommendation:** **MOVE TO APPENDIX**
  - **Reason:** Figure 3 already establishes the null for the primary outcome. Having a second, nearly identical-looking null plot in the main text is slightly redundant. The results are already summarized in Table 3.

### Figure 5: "Treatment vs. Placebo: Behavioral Health and Personal Care Event Studies"
**Page:** 19
- **Formatting:** Overlaying two event studies is a high-level visualization technique favored by top journals.
- **Clarity:** Good use of colors and legend.
- **Storytelling:** Very strong. It acts as a "triple-difference" visual, showing that the policy (which couldn't affect personal care) indeed had no differential effect.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Goodman-Bacon Decomposition of TWFE Estimate"
**Page:** 20
- **Formatting:** Excellent. Standard scatter plot for this diagnostic.
- **Clarity:** High. 
- **Storytelling:** Essential for modern DiD papers to address the "forbidden comparisons" critique. It proves the TWFE isn't biased by weight.
- **Labeling:** Legends and source are perfect.
- **Recommendation:** **MOVE TO APPENDIX**
  - **Reason:** While methodologically important, the main text already states that 88% of the weight is on clean comparisons. This visual is a "diagnostic" and is usually relegated to the appendix in journals like the AER.

### Figure 7: "Leave-One-Out Sensitivity Analysis"
**Page:** 21
- **Formatting:** Professional forest plot.
- **Clarity:** Clear state abbreviations.
- **Storytelling:** Robustness check to ensure no single state (like CA or NY) drives the null.
- **Labeling:** Note explains the orange line.
- **Recommendation:** **MOVE TO APPENDIX**
  - **Reason:** Supporting robustness, not central to the story.

---

## Appendix Exhibits

### Table 4: "Telehealth Payment Parity Law Adoption Dates"
**Page:** 31
- **Formatting:** Clean list.
- **Clarity:** High. Includes the statute numbers, which is great for transparency.
- **Storytelling:** Primary data source for the treatment variable.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 8: "State Adoption of Medicaid Telehealth Payment Parity"
**Page:** 33
- **Formatting:** The tile map (hex map style) is very effective.
- **Clarity:** Much easier to read than a standard US map.
- **Storytelling:** Provides the geographic distribution of treatment.
- **Recommendation:** **PROMOTE TO MAIN TEXT**
  - **Reason:** This is a high-quality visual that gives the reader an immediate sense of the "Who and Where." It would look great in Section 2.

---

## Overall Assessment

- **Exhibit count:** 3 main tables, 7 main figures, 1 appendix table, 1 appendix figure.
- **General quality:** Extremely high. The author uses modern R-based visualization tools (`ggplot2`, `did`, `fixest`) that produce the "clean" aesthetic required by top-tier journals.
- **Strongest exhibits:** Figure 5 (Treatment vs. Placebo overlay) and Figure 8 (Tile Map).
- **Weakest exhibits:** Figure 4 (Redundant with Fig 3) and Figure 6 (Too technical for main text flow).
- **Missing exhibits:** 
  - **Heterogeneity Table:** The text mentions the 2021 cohort vs. 2022 cohort results. A small table or panel showing these group-specific ATTs would be better than just citing them in-text.
- **Top 3 improvements:**
  1. **Consolidate Robustness:** Move the Goodman-Bacon (Fig 6) and Leave-One-Out (Fig 7) to the Appendix to keep the main text focused on the result and the placebo.
  2. **Promote Geographic Visual:** Move the tile map (Fig 8) to the main text (Section 2) to replace or complement the adoption timeline (Fig 1).
  3. **Y-Axis Standardization:** In Figures 3, 4, and 5, ensure the Y-axis limits are consistent across the plots (e.g., -0.2 to 0.2) to allow the reader to visually compare the "tightness" of the null across different outcomes.